BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28615266)

  • 1. Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.
    Fragale A; Romagnoli G; Licursi V; Buoncervello M; Del Vecchio G; Giuliani C; Parlato S; Leone C; De Angelis M; Canini I; Toschi E; Belardelli F; Negri R; Capone I; Presutti C; Gabriele L
    Cancer Immunol Res; 2017 Jul; 5(7):604-616. PubMed ID: 28615266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
    Buoncervello M; Romagnoli G; Buccarelli M; Fragale A; Toschi E; Parlato S; Lucchetti D; Macchia D; Spada M; Canini I; Sanchez M; Falchi M; Musella M; Biffoni M; Belardelli F; Capone I; Sgambato A; Vitiani LR; Gabriele L
    Oncotarget; 2016 May; 7(18):26361-73. PubMed ID: 27028869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
    Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M
    Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively induce dendritic cell maturation in vitro.
    Hiraide A; Hiroishi K; Ishii S; Eguchi J; Imawari M
    Anticancer Res; 2006; 26(1A):211-8. PubMed ID: 16475701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.
    Omori R; Eguchi J; Hiroishi K; Ishii S; Hiraide A; Sakaki M; Doi H; Kajiwara A; Ito T; Kogo M; Imawari M
    Cancer Gene Ther; 2012 Sep; 19(9):637-43. PubMed ID: 22790963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells.
    Yang H; Yamazaki T; Pietrocola F; Zhou H; Zitvogel L; Ma Y; Kroemer G
    Cancer Res; 2015 Sep; 75(18):3812-22. PubMed ID: 26208907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2.
    Zimmerer JM; Lehman AM; Ruppert AS; Noble CW; Olencki T; Walker MJ; Kendra K; Carson WE
    Clin Cancer Res; 2008 Mar; 14(5):1438-45. PubMed ID: 18316567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction.
    Eguchi J; Hiroishi K; Ishii S; Baba T; Matsumura T; Hiraide A; Okada H; Imawari M
    Gene Ther; 2005 May; 12(9):733-41. PubMed ID: 15772692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
    Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
    Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
    Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.
    Detournay O; Mazouz N; Goldman M; Toungouz M
    Hum Immunol; 2005 May; 66(5):460-8. PubMed ID: 15935883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
    Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
    J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity.
    Fournier P; Arnold A; Wilden H; Schirrmacher V
    Int J Oncol; 2012 Mar; 40(3):840-50. PubMed ID: 22102168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.
    Solis M; Goubau D; Romieu-Mourez R; Genin P; Civas A; Hiscott J
    Biochem Pharmacol; 2006 Nov; 72(11):1469-76. PubMed ID: 16846591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
    Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
    J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
    Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
    J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction.
    Yamaguchi M; Kitagawa Y; Zhou M; Itoh M; Gotoh B
    FEBS Lett; 2014 Jan; 588(1):28-34. PubMed ID: 24269682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.